Long-term Morbidity and Mortality After Implantable Cardioverter-defibrillator Implantation with Procedural Complication: A Report from the National Cardiovascular Data Registry
Overview
Affiliations
Background: Long-term outcomes and predictors of mortality after implantable cardioverter-defibrillator (ICD) implantation related complication are unclear.
Objective: The purpose of this study was to determine the risk of mortality and hospitalization after complication during ICD implantation and identify predictors of adverse outcomes.
Methods: We performed a retrospective registry study of Medicare beneficiaries who were first-time ICD recipients enrolled in the National Cardiovascular Data Registry ICD Registry between January 2006 and March 2010. Mortality and hospitalization rates were examined using Kaplan-Meier survival analysis and multivariable Cox proportional hazards regression analysis. Covariates associated with mortality 3 years after ICD implantation complication were investigated.
Results: The study cohort comprised 136,143 Medicare beneficiaries. Complications during the index hospitalization occurred in 7046 patients (5.18%), and complications within 90 days of device implantation occurred in 10,005 patients (7.34%). In adjusted analyses, complications within 90 days of implantation were associated with an increased risk of all-cause mortality at 1 year (hazard ratio [HR] 1.13; 95% confidence interval [CI] 1.05-1.20; P = .006) and 3 years (HR 1.09; 95% CI 1.05-1.13; P <.0001). These results were consistent for a combined endpoint of all-cause mortality or hospitalization. Patient, device, and hospital characteristics associated with 3-year mortality were similar between those with and those without complications.
Conclusion: Among Medicare beneficiaries, the occurrence of complications within 90 days of ICD implantation was associated with increased risk of all-cause mortality and all-cause mortality or hospitalization at 1 and 3 years. Patient, procedure, and hospital characteristics associated with mortality at 3 years after implantation were similar regardless of whether acute procedural complication occurred.
Chu M, Tam W, Lam K, Chan C, Evora M, Lam U Cureus. 2024; 16(8):e67003.
PMID: 39286713 PMC: 11403653. DOI: 10.7759/cureus.67003.
Mascheroni J, Stockburger M, Patwala A, Mont L, Rao A, Retzlaff H Europace. 2024; 26(9.
PMID: 39257213 PMC: 11412769. DOI: 10.1093/europace/euae229.
An unusual cause of inappropriate shocks delivered by an implantable cardioverter defibrillator.
Baldauf B, Lau E, Giaccardi M, Bonnemeier H BMC Cardiovasc Disord. 2024; 24(1):380.
PMID: 39039491 PMC: 11264391. DOI: 10.1186/s12872-024-04038-z.
Forman J, Murtagh E, Cheung J, Chakrabarti S, Macleod S, MacEwing C PEC Innov. 2023; 1:100104.
PMID: 37213750 PMC: 10194333. DOI: 10.1016/j.pecinn.2022.100104.
Khurshid S, Chen W, Bode W, Wasfy J, Chhatwal J, Lubitz S J Am Heart Assoc. 2021; 10(16):e021144.
PMID: 34387130 PMC: 8475040. DOI: 10.1161/JAHA.121.021144.